Ads
related to: merck & co.
Search results
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 4 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 54 minutes agoJeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects ...
MRK stock rated a Sell by Societe Generale – Knox Daily
Knox Daily· 1 day agoMerck & Co Inc’s filing revealed that its 10% Owner Merck & Co., Inc. acquired Company’s shares for reported $492.14 ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
WHTC 1450 Holland· 10 hours ago(Reuters) -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 18 hours agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Merck to buy EyeBio in a deal that could valued at up to $3 billion
Market Watch· 1 hour agoannounced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused...
Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Simply Wall St. via Yahoo Finance· 1 day agoMerck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 4 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 1 day agoMerck & Co (MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
Merck On Track for Largest Percent Decrease Since October 2023 — Data Talk
Morningstar· 22 hours agoMerck & Co., Inc. (MRK) is currently at $126.30, down $3.19 or 2.46% --Would be lowest close since April 19, 2024, when it closed at $125.78 --On pace for ...